These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 8567111)
21. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach. Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490 [TBL] [Abstract][Full Text] [Related]
22. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971 [TBL] [Abstract][Full Text] [Related]
23. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia. Sugg SL; Ezzat S; Zheng L; Rosen IB; Freeman JL; Asa SL Clin Endocrinol (Oxf); 1998 Nov; 49(5):629-37. PubMed ID: 10197079 [TBL] [Abstract][Full Text] [Related]
25. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms. Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730 [TBL] [Abstract][Full Text] [Related]
26. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis. Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390 [TBL] [Abstract][Full Text] [Related]
27. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization. Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930 [TBL] [Abstract][Full Text] [Related]
28. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. Zeng Q; Chen G; Vlantis A; Tse G; van Hasselt C J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520 [TBL] [Abstract][Full Text] [Related]
30. Epithelial membrane antigen and S-100 protein expression in benign and malignant papillary thyroid neoplasms. Kilicarslan B; Pesterelli EH; Oren N; Sargin FC; Karpuzoglu G Adv Clin Path; 2000 Oct; 4(4):155-8. PubMed ID: 11436147 [TBL] [Abstract][Full Text] [Related]
31. Decreased expression of retinoid X receptor isoforms in human thyroid carcinomas. Takiyama Y; Miyokawa N; Sugawara A; Kato S; Ito K; Sato K; Oikawa K; Kobayashi H; Kimura S; Tateno M J Clin Endocrinol Metab; 2004 Nov; 89(11):5851-61. PubMed ID: 15531552 [TBL] [Abstract][Full Text] [Related]
32. Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics. Irani S; Salajegheh A; Gopalan V; Smith RA; Lam AK Ann Diagn Pathol; 2014 Apr; 18(2):43-8. PubMed ID: 24332749 [TBL] [Abstract][Full Text] [Related]
33. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. Ruco LP; Stoppacciaro A; Ballarini F; Prat M; Scarpino S J Pathol; 2001 May; 194(1):4-8. PubMed ID: 11329134 [TBL] [Abstract][Full Text] [Related]
34. Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas. Shin E; Hong SW; Kim SH; Yang WI Yonsei Med J; 2004 Apr; 45(2):306-13. PubMed ID: 15119004 [TBL] [Abstract][Full Text] [Related]
35. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation. Ng SB; Sittampalam K; Goh YH; Eu KW Pathology; 2003 Feb; 35(1):42-6. PubMed ID: 12701683 [TBL] [Abstract][Full Text] [Related]
36. Expression, regulation and function of autotaxin in thyroid carcinomas. Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116 [TBL] [Abstract][Full Text] [Related]
37. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135 [TBL] [Abstract][Full Text] [Related]
38. EGF-receptors in human normal and pathological thyroid tissue. Westermark K; Lundqvist M; Wallin G; Dahlman T; Hacker GW; Heldin NE; Grimelius L Histopathology; 1996 Mar; 28(3):221-7. PubMed ID: 8729040 [TBL] [Abstract][Full Text] [Related]
39. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790 [TBL] [Abstract][Full Text] [Related]
40. Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas. Ulisse S; Baldini E; Toller M; Marchioni E; Giacomelli L; De Antoni E; Ferretti E; Marzullo A; Graziano FM; Trimboli P; Biordi L; Curcio F; Gulino A; Ambesi-Impiombato FS; D'Armiento M Eur J Cancer; 2006 Oct; 42(15):2631-8. PubMed ID: 16928445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]